NCT04272333 2022-04-14
Intratumoral Microdosing of Motolimod in HNSCC
Presage Biosciences
Phase EARLY_PHASE1 Terminated
Clinical Trials
3 trialsNCT01836029 2019-10-29
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Celgene
Phase 2 Completed
NCT02124850 2019-10-25
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
Celgene
Phase 1 Terminated